Articles producció científica> Medicina i Cirurgia

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis

  • Dades identificatives

    Identificador: imarina:5131022
    Autors:
    Simpson, JoanneCastagno, DavideDoughty, Rob N.Poppe, Katrina K.Earle, NikkiSquire, IainRichards, MarkAndersson, BertEzekowitz, Justin A.Komajda, MichelPetrie, Mark C.McAlister, Finlay A.Gamble, Greg D.Whalley, Gillian A.McMurray, John J. V.Meta-Anal Global Grp Chronic Heart
    Resum:
    To investigate the relationship between heart rate and survival in patients with heart failure (HF) and coexisting atrial fibrillation (AF).Patients with AF included in the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) meta-analysis were the main focus of this analysis (3259 patients from 17 studies). The outcome was all-cause mortality at 3 years. Heart rate was analysed as a categorical (tertiles; T1 ?77 b.p.m., T2 78-98 b.p.m., T3 ?98 b.p.m.) and continuous variable. Cox proportional hazard models were used to compare the risk of all-cause death between tertiles of baseline heart rate. Patients in the highest tertile were more often female, less likely to have an ischaemic aetiology or diabetes, had a lower ejection fraction but higher blood pressure and New York Heart Association (NYHA) class. Higher heart rate was associated with higher mortality in patients with sinus rhythm (SR) but not in those in AF. In patients with heart failure and reduced ejection fraction (HF-REF) and AF, death rates per 100 patient years were lowest in the highest heart rate tertile (T1 18.9 vs. T3 15.9) but this difference was not statistically significant (P = 0.10). In patients with heart failure and preserved ejection fraction (HF-PEF), death rates per 100 patient years were highest in the highest heart rate tertile (T1 14.6 vs. T3 16.0, P = 0.014). However, after adjustment for other important prognostic variables, higher heart rate was no longer associated with higher mortality in HF-PEF (or HF-REF).In this meta-analysis of patients with HF, heart rate does not have the same prognostic significance in patients in AF as it does in those in SR, irrespective of ejection fraction or treatment with beta-blocker.© 2015 The Authors European Journal of Heart Failure © 2015 Eu
  • Altres:

    Autor segons l'article: Simpson, Joanne; Castagno, Davide; Doughty, Rob N.; Poppe, Katrina K.; Earle, Nikki; Squire, Iain; Richards, Mark; Andersson, Bert; Ezekowitz, Justin A.; Komajda, Michel; Petrie, Mark C.; McAlister, Finlay A.; Gamble, Greg D.; Whalley, Gillian A.; McMurray, John J. V.;Meta-Anal Global Grp Chronic Heart
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Bardají Ruiz, Alfredo
    Paraules clau: Ventricular systolic dysfunction Survival Strict rate control Prognosis Preserved ejection fraction Natriuretic peptide Mortality Morbidity Heart rate Heart failure Follow-up European-society Ejection fraction Beta-blockers Atrial fibrillation preserved ejection fraction heart rate heart failure atrial fibrillation
    Resum: To investigate the relationship between heart rate and survival in patients with heart failure (HF) and coexisting atrial fibrillation (AF).Patients with AF included in the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) meta-analysis were the main focus of this analysis (3259 patients from 17 studies). The outcome was all-cause mortality at 3 years. Heart rate was analysed as a categorical (tertiles; T1 ?77 b.p.m., T2 78-98 b.p.m., T3 ?98 b.p.m.) and continuous variable. Cox proportional hazard models were used to compare the risk of all-cause death between tertiles of baseline heart rate. Patients in the highest tertile were more often female, less likely to have an ischaemic aetiology or diabetes, had a lower ejection fraction but higher blood pressure and New York Heart Association (NYHA) class. Higher heart rate was associated with higher mortality in patients with sinus rhythm (SR) but not in those in AF. In patients with heart failure and reduced ejection fraction (HF-REF) and AF, death rates per 100 patient years were lowest in the highest heart rate tertile (T1 18.9 vs. T3 15.9) but this difference was not statistically significant (P = 0.10). In patients with heart failure and preserved ejection fraction (HF-PEF), death rates per 100 patient years were highest in the highest heart rate tertile (T1 14.6 vs. T3 16.0, P = 0.014). However, after adjustment for other important prognostic variables, higher heart rate was no longer associated with higher mortality in HF-PEF (or HF-REF).In this meta-analysis of patients with HF, heart rate does not have the same prognostic significance in patients in AF as it does in those in SR, irrespective of ejection fraction or treatment with beta-blocker.© 2015 The Authors European Journal of Heart Failure © 2015 European Society of Cardiology.
    Àrees temàtiques: Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Enfermagem Educação física Ciências biológicas ii Ciências biológicas i Cardiology and cardiovascular medicine Cardiac & cardiovascular systems
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: alfredo.bardaji@urv.cat
    Identificador de l'autor: 0000-0003-1900-6974
    Data d'alta del registre: 2024-09-07
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://onlinelibrary.wiley.com/doi/10.1093/eurjhf/hft101
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: European Journal Of Heart Failure. 17 (11): 1182-1191
    Referència de l'ítem segons les normes APA: Simpson, Joanne; Castagno, Davide; Doughty, Rob N.; Poppe, Katrina K.; Earle, Nikki; Squire, Iain; Richards, Mark; Andersson, Bert; Ezekowitz, Justin (2015). Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis. European Journal Of Heart Failure, 17(11), 1182-1191. DOI: 10.1002/ejhf.346
    DOI de l'article: 10.1002/ejhf.346
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2015
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Cardiac & Cardiovascular Systems,Cardiology and Cardiovascular Medicine
    Ventricular systolic dysfunction
    Survival
    Strict rate control
    Prognosis
    Preserved ejection fraction
    Natriuretic peptide
    Mortality
    Morbidity
    Heart rate
    Heart failure
    Follow-up
    European-society
    Ejection fraction
    Beta-blockers
    Atrial fibrillation
    preserved ejection fraction
    heart rate
    heart failure
    atrial fibrillation
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Enfermagem
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Cardiology and cardiovascular medicine
    Cardiac & cardiovascular systems
  • Documents:

  • Cerca a google

    Search to google scholar